Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Uterine Cervical Neoplasms 7Colorectal Neoplasms 7Neoplasms 6Breast Neoplasms 6Lung Neoplasms 4Uterine Cervical Dysplasia 2Prostatic Neoplasms 2Papillomavirus Infections 2End Stage Liver Disease 2Warts 1Urinary Bladder Neoplasms 1Tinea 1Smoking 1Skin Neoplasms 1Pancreatic Neoplasms 1Nevus 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Molluscum Contagiosum 1Melanoma 1Lymphoma, Non-Hodgkin 1Lung Cancer Screening 1Liver Neoplasms 1Kidney Failure, Chronic 1Keratosis, Actinic 1Intestinal Neoplasms 1Impetigo 1Herpes Zoster 1Hepatitis C 1Heart Diseases 1

Interventions

Nutrition Assessment 2liposomal doxorubicin 1Vitamin E 1Vitamin D 1Tomography, X-Ray Computed 1Tomography, Emission-Computed 1Therapeutics 1Progestins 1Positron-Emission Tomography 1Methods 1Mass Screening 1Magnetic Resonance Imaging 1Hormone Replacement Therapy 1Estrogens 1Estrogen Replacement Therapy 1Educational Status 1Dietary Supplements 1Diet, Fat-Restricted 1Case Management 1Calcium 1Breathing Exercises 1Atorvastatin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Heart Diseases × Mass Screening × Clear all
NCT01714271 2023-10-02

Promotora-based Latino Family CVD Risk Reduction

University of California, Los Angeles

Phase 2 Completed
204 enrolled

Heart Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡